Low Dose

Context: Hypoglycemia is emerging as a risk for cardiovascular events in diabetes. We hypothesized that hypoglycemia activates

[1]  B. Zinman,et al.  Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience , 2018, Diabetes Care.

[2]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[3]  B. Zinman,et al.  DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality , 2017, Diabetologia.

[4]  I. Macdonald,et al.  Cardiac Autonomic Regulation and Repolarization During Acute Experimental Hypoglycemia in Type 2 Diabetes , 2017, Diabetes.

[5]  M. Netea,et al.  Proinflammatory Effects of Hypoglycemia in Humans With or Without Diabetes , 2017, Diabetes.

[6]  C. Weber,et al.  Role and analysis of monocyte subsets in cardiovascular disease , 2016, Thrombosis and Haemostasis.

[7]  Susan C. Hu,et al.  A Population-Based Study of All-Cause Mortality and Cardiovascular Disease in Association With Prior History of Hypoglycemia Among Patients With Type 1 Diabetes , 2016, Diabetes Care.

[8]  Daniel C. Lee,et al.  The Kinetics of Circulating Monocyte Subsets and Monocyte-Platelet Aggregates in the Acute Phase of ST-Elevation Myocardial Infarction , 2016, Medicine.

[9]  M. Reilly,et al.  Innate Immunity and Cardiometabolic Disease Human Experimental Endotoxemia in Modeling the Pathophysiology, Genomics, and Therapeutics of Innate Immunity in Complex Cardiometabolic Diseases Brief Review , 2022 .

[10]  S. Davis,et al.  Effects of Acute and Antecedent Hypoglycemia on Endothelial Function and Markers of Atherothrombotic Balance in Healthy Humans , 2015, Diabetes.

[11]  K. Khunti,et al.  Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study , 2014, Diabetes Care.

[12]  A. Suffredini,et al.  Human Endotoxin Administration as an Experimental Model in Drug Development , 2014, Clinical pharmacology and therapeutics.

[13]  Alan Bernjak,et al.  Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk , 2014, Diabetes.

[14]  A. Goto,et al.  Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis , 2013, BMJ.

[15]  P. Hsu,et al.  Association of Clinical Symptomatic Hypoglycemia With Cardiovascular Events and Total Mortality in Type 2 Diabetes , 2013, Diabetes Care.

[16]  G. Lip,et al.  Increased Formation of Monocyte-Platelet Aggregates in Ischemic Heart Failure , 2013, Circulation. Heart failure.

[17]  P. Holt,et al.  The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis , 2012, Diabetologia.

[18]  G. Lip,et al.  The CD14++CD16+ monocyte subset and monocyte‐platelet interactions in patients with ST‐elevation myocardial infarction , 2012, Journal of thrombosis and haemostasis : JTH.

[19]  Charles P. Lin,et al.  Myocardial infarction accelerates atherosclerosis , 2012, Nature.

[20]  B. Hedblad,et al.  Elevated CD14++CD16− Monocytes Predict Cardiovascular Events , 2012, Circulation. Cardiovascular genetics.

[21]  Roy Taylor,et al.  Periodontitis and diabetes: a two-way relationship , 2011, Diabetologia.

[22]  A. Tsapas,et al.  Effect of Epinephrine and Insulin Resistance on Human Monocytes Obtained From Lean and Obese Healthy Participants: A Pilot Study , 2011, Angiology.

[23]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[24]  V. Evangelista,et al.  ATVB in Focus Platelets Unplugged: Focus on Platelet Biology , 2010 .

[25]  Silvano Sozzani,et al.  Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.

[26]  Mark Woodward,et al.  Severe hypoglycemia and risks of vascular events and death. , 2010, The New England journal of medicine.

[27]  Hiroto Tsujioka,et al.  Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. , 2010, Atherosclerosis.

[28]  P. Dandona,et al.  Insulin Suppresses Endotoxin-Induced Oxidative, Nitrosative, and Inflammatory Stress in Humans , 2010, Diabetes Care.

[29]  A. Ertl,et al.  Effects of Acute Hypoglycemia on Inflammatory and Pro-atherothrombotic Biomarkers in Individuals With Type 1 Diabetes and Healthy Individuals , 2010, Diabetes Care.

[30]  D. Newby,et al.  Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation , 2010, Diabetes Care.

[31]  J. Born,et al.  Selective Mobilization of Cytotoxic Leukocytes by Epinephrine , 2009, The Journal of Immunology.

[32]  A. Kitabchi,et al.  Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. , 2009, Metabolism: Clinical and Experimental.

[33]  Anita C. Thomas,et al.  Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes , 2009, Thrombosis and Haemostasis.

[34]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[35]  P. Cryer.  The Barrier of Hypoglycemia in Diabetes , 2008, Diabetes.

[36]  K. Fox,et al.  Monocyte Functional Responsiveness After PSGL-1–Mediated Platelet Adhesion Is Dependent on Platelet Activation Status , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[37]  P. Mills,et al.  Effects of an exercise challenge on mobilization and surface marker expression of monocyte subsets in individuals with normal vs. elevated blood pressure , 2008, Brain, Behavior, and Immunity.

[38]  P. Quax,et al.  Activation of the innate immune system in atherosclerotic disease. , 2007, Current pharmaceutical design.

[39]  R. Goldberg,et al.  Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. , 2001, Journal of the American College of Cardiology.

[40]  M. Furman,et al.  Circulating Monocyte-Platelet Aggregates Are a More Sensitive Marker of In Vivo Platelet Activation Than Platelet Surface P-Selectin: Studies in Baboons, Human Coronary Intervention, and Human Acute Myocardial Infarction , 2001, Circulation.

[41]  M. Mack,et al.  Selective mobilization of CD14(+)CD16(+) monocytes by exercise. , 2000, American journal of physiology. Cell physiology.

[42]  A. Aljada,et al.  Effect of insulin on human aortic endothelial nitric oxide synthase. , 2000, Metabolism: clinical and experimental.

[43]  F. Neumann,et al.  Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. , 1997, Circulation.

[44]  AlbertSchömig,et al.  Induction of Cytokine Expression in Leukocytes by Binding of Thrombin-Stimulated Platelets , 1997 .

[45]  G. Lowe,et al.  Effects of acute insulin-induced hypoglycaemia on haemostasis, fibrinolysis and haemorheology in insulin-dependent diabetic patients and control subjects. , 1991, Clinical science.

[46]  M. Trovati,et al.  Studies on Mechanisms Involved in Hypoglycemia-Induced Platelet Activation , 1986, Diabetes.

[47]  S. Madsbad,et al.  Changes in Platelet Function, Blood Coagulation and Fibrinolysis During Insulin-Induced Hypoglycaemia in Juvenile Diabetics and Normal Subjects , 1982, Thrombosis and Haemostasis.

[48]  D. Mikhailidis,et al.  Platelet aggregation studies during transient hypoglycaemia: a potential method for evaluating platelet function. , 1979, Journal of clinical pathology.

[49]  D. Fliser,et al.  CD14 CD16 Monocytes Independently Predict Cardiovascular Events , 2012 .

[50]  D. Fliser,et al.  CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. , 2011, European heart journal.

[51]  Michael E. Miller,et al.  ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP. EFFECTS OF INTENSIVE GLUCOSE LOWERING IN TYPE 2 DIABETES , 2010 .

[52]  S. Schinner.  Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[53]  D. Power.  Standards of medical care in diabetes. , 2006, Diabetes care.

[54]  P. Hordijk,et al.  Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. , 2006, Journal of leukocyte biology.